Summary
IDEXX Laboratories, Inc. (IDXX) announced a change in its Board of Directors through an 8-K filing on July 12, 2023. The company elected Irene Chang Britt as an independent Class I Director, effective July 11, 2023. This appointment also includes her joining the Audit Committee and the Compensation and Talent Committee. To accommodate this addition, the size of the Board has been expanded from ten to eleven directors, with the number of Class I Directors increasing from three to four. Ms. Chang Britt's appointment is notable as she has no disclosed related-party transactions. Her compensation will align with that of other non-employee directors, with adjustments reflecting recent increases in annual retainers and equity awards approved in May 2023. Specifically, her annual cash retainer will be $90,000, and her annual equity compensation will be valued at $250,000, split evenly between full-value awards and stock options. These will be prorated to reflect her service period from July 11, 2023, to the 2024 annual meeting. The company also issued a press release on July 12, 2023, to announce this board change.
Key Highlights
- 1Irene Chang Britt elected as an independent Class I Director, effective July 11, 2023.
- 2Ms. Chang Britt appointed to the Audit Committee and Compensation and Talent Committee.
- 3Board size increased from ten to eleven directors.
- 4No related person transactions disclosed concerning Ms. Chang Britt.
- 5Director compensation updated: annual cash retainer increased to $90,000 and annual equity award value to $250,000.
- 6Ms. Chang Britt's compensation will be prorated for her initial term.
- 7Press release issued on July 12, 2023, to announce the appointment.